Rezvilutamide for High-Risk Prostate Cancer After Surgery
Clinical trial NCT07444983 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07444983
- Sponsor
- Fujian Medical University Union Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-11
- Primary completion
- 2027-02-11
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.